Company intelligence / Profile preview

ThrombX Medical

San Mateo, California, United Statespmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Development stage: Commercial

Overview

The "ThrombX Retriever" demonstrated high rates of substantial reperfusion and functional independence with no device-related serious adverse events in a small European post-market study. A larger prospective trial was planned. The company was preparing for an IDE clinical study in the US but subsequently filed for Chapter 7 bankruptcy and ceased operations.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

ThrombX Retriever

Commercial

Indications: Acute ischemic stroke

Partnerships

Oliver Healthcare Packaging (medical packaging partner)

Beyond the preview

Go deeper on ThrombX Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ThrombX Medical.

Explore the full profile